Cel-Sci
CVM
#10549
Rank
โ‚น1.99 B
Marketcap
โ‚น113.93
Share price
-0.84%
Change (1 day)
-80.76%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น0.82 Billion

According to Cel-Sci 's latest financial reports the company's total debt is โ‚น0.82 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-09-30โ‚น0.83 B-14.43%
2024-09-30โ‚น0.97 B-13.7%
2023-09-30โ‚น1.12 B-9.37%
2022-09-30โ‚น1.24 B5.02%
2021-09-30โ‚น1.18 B15.45%
2020-09-30โ‚น1.02 B7.23%
2019-09-30โ‚น0.95 B-1.25%
2018-09-30โ‚น0.97 B4.56%
2017-09-30โ‚น0.92 B6.68%
2016-09-30โ‚น0.86 B-4.43%
2015-09-30โ‚น0.90 B1212.44%
2014-09-30โ‚น69.33 M-2.23%
2013-09-30โ‚น70.91 M21.54%
2012-09-30โ‚น58.34 M-76.22%
2011-09-30โ‚น0.24 B398.78%
2010-09-30โ‚น49.2 M-6.93%
2009-09-30โ‚น52.86 M467.59%
2008-09-30โ‚น9.31 M
2005-09-30โ‚น0.13 M-4.34%
2004-09-30โ‚น0.13 M-99.66%
2003-09-30โ‚น39.99 M-53.41%
2002-09-30โ‚น85.85 M5645.84%
2001-09-30โ‚น1.49 M30.98%
2000-09-30โ‚น1.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น5.309 T 645,876.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น5.534 T 673,319.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น16.91 B 1,957.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚น0.12 B-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.632 T 198,520.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
โ‚น78.95 B 9,506.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น55.38 B 6,638.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น37.55 M-95.43%๐Ÿ‡บ๐Ÿ‡ธ USA